Influence of nonregional lymph node metastasis as a prognostic factor in metastatic prostate cancer patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, S. | - |
dc.contributor.author | Kang, S.G. | - |
dc.contributor.author | Tae, B.S. | - |
dc.contributor.author | Cheon, J. | - |
dc.date.accessioned | 2021-09-07T04:14:10Z | - |
dc.date.available | 2021-09-07T04:14:10Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 2005-6737 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/110672 | - |
dc.description.abstract | Purpose: In advanced prostate cancer, malignant cells generally tend to spread into the bone, and metastasis into nonregional lymph nodes (NRLNs) at the time of initial diagnosis is relatively rare. We investigated the prognostic significance of NRLN metastasis in patients receiving hormonal therapy and chemotherapy. Materials and Methods: From February 2005 to August 2011, we identified 105 patients who had metastatic prostate cancer. First, we assessed the prognostic effect of NRLN metastasis on the prostate-specific antigen response through logistic regression and the progression-free time to castration-resistant prostate cancer (CRPC) by using the Cox proportional hazard regression model. Second, we investigated the prognostic influence of NRLN metastasis on the chemotherapy response through logistic regression and on cancer-specific survival of CRPC patients receiving chemotherapy by using Cox proportional analysis. Results: Of these 105 patients, 12 patients (11.4%) had only NRLN metastases without bone metastases. Progression-free time to CRPC was significantly less in patients with NRLN metastases by Cox proportional hazard regression multivariate analysis (p=0.020). However, NRLN metastasis was not an independent factor for predicting the response to chemotherapy in CRPC patients, and NRLN metastasis did not reduce cancer-specific survival in the multivariate analysis. Conclusions: Twelve (11.4%) of 105 patients with NRLN metastases had lymph node metastases without bone metastases. In addition, NRLN metastasis was a significant prognostic factor for predicting reduced progression-free time to CRPC. Thus, although we speculate that prostate cancer with NRLN metastasis exhibits unique tumor biology, additional molecular and genetic studies are needed. © The Korean Urological Association, 2012. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.subject | alkaline phosphatase | - |
dc.subject | hemoglobin | - |
dc.subject | lactate dehydrogenase | - |
dc.subject | prostate specific antigen | - |
dc.subject | advanced cancer | - |
dc.subject | aged | - |
dc.subject | article | - |
dc.subject | bone metastasis | - |
dc.subject | cancer chemotherapy | - |
dc.subject | cancer hormone therapy | - |
dc.subject | cancer prognosis | - |
dc.subject | cancer specific survival | - |
dc.subject | cancer staging | - |
dc.subject | castration resistant prostate cancer | - |
dc.subject | human | - |
dc.subject | lymph node metastasis | - |
dc.subject | major clinical study | - |
dc.subject | male | - |
dc.subject | organ size | - |
dc.subject | predictive value | - |
dc.subject | progression free survival | - |
dc.subject | prostate cancer | - |
dc.title | Influence of nonregional lymph node metastasis as a prognostic factor in metastatic prostate cancer patients | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kang, S.G. | - |
dc.identifier.doi | 10.4111/kju.2012.53.10.673 | - |
dc.identifier.scopusid | 2-s2.0-84868564324 | - |
dc.identifier.bibliographicCitation | Korean Journal of Urology, v.53, no.10, pp.673 - 679 | - |
dc.relation.isPartOf | Korean Journal of Urology | - |
dc.citation.title | Korean Journal of Urology | - |
dc.citation.volume | 53 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 673 | - |
dc.citation.endPage | 679 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001706020 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | alkaline phosphatase | - |
dc.subject.keywordPlus | hemoglobin | - |
dc.subject.keywordPlus | lactate dehydrogenase | - |
dc.subject.keywordPlus | prostate specific antigen | - |
dc.subject.keywordPlus | advanced cancer | - |
dc.subject.keywordPlus | aged | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | bone metastasis | - |
dc.subject.keywordPlus | cancer chemotherapy | - |
dc.subject.keywordPlus | cancer hormone therapy | - |
dc.subject.keywordPlus | cancer prognosis | - |
dc.subject.keywordPlus | cancer specific survival | - |
dc.subject.keywordPlus | cancer staging | - |
dc.subject.keywordPlus | castration resistant prostate cancer | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | lymph node metastasis | - |
dc.subject.keywordPlus | major clinical study | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | organ size | - |
dc.subject.keywordPlus | predictive value | - |
dc.subject.keywordPlus | progression free survival | - |
dc.subject.keywordPlus | prostate cancer | - |
dc.subject.keywordAuthor | Lymphatic metastasis | - |
dc.subject.keywordAuthor | Prognosis | - |
dc.subject.keywordAuthor | Prostatic neoplasm | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.